Core Scientific, Inc./tx (CORZZ) stock
CORZZNasdaqFinance ServicesFiscal year ends December 31Also trades as CORZ, CORZR, CORZW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 2/30223% above fair value
$12.85−1.46 (-10.20%)
Close on Oct 30, 2026Market cap $4.13BP/E –Yield –
Core Scientific r&d expenses
Research and development expenses are spending on new products and technology.
Core Scientific's R&D Expenses for the twelve months ending Dec 31, 2024 was $11.83M, up 64.7% year over year. For fiscal 2024 it was $11.83M, up 64.7% from the year before. The highest annual figure on record is $26.96M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $11.83M | +64.7% |
| FY2023 | Dec 31, 2023 | $7.18M | -73.4% |
| FY2022 | Dec 31, 2022 | $26.96M | +251.3% |
| FY2021 | Dec 31, 2021 | $7.67M | +45.6% |
| FY2020 | Dec 31, 2020 | $5.27M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $5.02M | +167.4% |
| Q3 FY2024 | Sep 30, 2024 | $2.84M | +26.1% |
| Q2 FY2024 | Jun 30, 2024 | $2.17M | +32.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.80M | +27.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.88M | -29.4% |
| Q3 FY2023 | Sep 30, 2023 | $2.25M | -63.6% |
| Q2 FY2023 | Jun 30, 2023 | $1.64M | -88.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.42M | -57.6% |
| Q4 FY2022 | Dec 31, 2022 | $2.66M | -22.8% |
| Q3 FY2022 | Sep 30, 2022 | $6.19M | +290.4% |
| Q2 FY2022 | Jun 30, 2022 | $14.77M | +928.0% |
| Q1 FY2022 | Mar 31, 2022 | $3.34M | +176.5% |
| Q4 FY2021 | Dec 31, 2021 | $3.44M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.59M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.44M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.21M | – |